Literature DB >> 16721258

Systemic lupus erythematosus in Asturias, Spain: clinical and serologic features.

Jesús Gómez1, Ana Suárez, Patricia López, Lourdes Mozo, José Bernardino Díaz, Carmen Gutiérrez.   

Abstract

Asturias is an autonomous region in the north of Spain with historical and anthropologic peculiarities. In the current report, we examine the main clinical and immunologic features of 363 patients with systemic lupus erythematosus (SLE), virtually the entire population of SLE patients in Asturias. We constructed a database with the clinical and immunologic features of all patients fulfilling the American College of Rheumatology criteria, based on the review of hospital records corresponding to blood samples received for antinuclear antibodies testing since 1992. Arthritis was the most frequently observed main clinical feature and neuropathy was the rarest. Male patients had a disease more frequently characterized by serositis (p<0.05) and neurologic disorder (p<0.01) than females, while children presented malar rash (p<0.05), fever (p<0.05), and kidney involvement (p<0.01) more often than adults. Late-onset patients were characterized by lower frequencies of malar rash (p<0.01), neurologic disorder (p<0.05), alopecia (p<0.01), and lymphadenopathy (p<0.05) than young adults. Numerous direct and inverse significant associations were found among clinical and immunologic features. The most relevant significant associations were neurologic disorder with lupus anticoagulant (p<0.01); kidney involvement with serositis (p<0.01) and DNA antibodies (p<0.05); and thrombosis with DNA antibodies (p<0.05), cardiolipin antibodies (p<0.01), and lupus anticoagulant (p<0.01). A low mortality was found in our series, although kidney involvement (p<0.05) and cardiolipin antibodies (p<0.05) are factors associated with poor survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16721258     DOI: 10.1097/01.md.0000224711.54886.b1

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  13 in total

Review 1.  A case of very late-onset systemic lupus erythematosus and updated pooled analysis of late-onset cases in the literature.

Authors:  Fang Chen; Lu Zhang; Guochun Wang; Bing Lin; Liying Wang
Journal:  Rheumatol Int       Date:  2011-09-07       Impact factor: 2.631

2.  Pulmonary manifestations in late versus early systemic lupus erythematosus: A systematic review and meta-analysis.

Authors:  Jennifer L Medlin; Karen E Hansen; Sara S McCoy; Christie M Bartels
Journal:  Semin Arthritis Rheum       Date:  2018-01-31       Impact factor: 5.532

Review 3.  A systematic review and meta-analysis of cutaneous manifestations in late- versus early-onset systemic lupus erythematosus.

Authors:  Jennifer L Medlin; Karen E Hansen; Sara R Fitz; Christie M Bartels
Journal:  Semin Arthritis Rheum       Date:  2016-01-21       Impact factor: 5.532

4.  Presenting manifestations of hemophagocytic syndrome in a male patient with systemic lupus erythematosus.

Authors:  Hirofumi Taki; Koichiro Shinoda; Hiroyuki Hounoki; Reina Ogawa; Ryuji Hayashi; Eiji Sugiyama; Kazuyuki Tobe
Journal:  Rheumatol Int       Date:  2009-04-19       Impact factor: 2.631

5.  Sex differences in patients with systemic lupus erythematosus from Northwest Spain.

Authors:  Maria D Alonso; Francisco Martínez-Vázquez; Leyre Riancho-Zarrabeitia; Teresa Díaz de Terán; Jose A Miranda-Filloy; Ricardo Blanco; Carlos González-Juanatey; Javier Llorca; Miguel A González-Gay
Journal:  Rheumatol Int       Date:  2013-06-28       Impact factor: 2.631

6.  Influence of Atg5 mutation in SLE depends on functional IL-10 genotype.

Authors:  Patricia López; Elisa Alonso-Pérez; Javier Rodríguez-Carrio; Ana Suárez
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

7.  Clinical & immunological characteristics in systemic lupus erythematosus patients.

Authors:  Maryam Rastin; Mahmoud Mahmoudi; Maryam Sahebari; Nafiseh Tabasi
Journal:  Indian J Med Res       Date:  2017-08       Impact factor: 2.375

8.  Common and specific associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies in systemic lupus erythematosus.

Authors:  Aurora Menéndez; Jesús Gómez; Luis Caminal-Montero; José Bernardino Díaz-López; Iván Cabezas-Rodríguez; Lourdes Mozo
Journal:  ScientificWorldJournal       Date:  2013-10-30

9.  Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients.

Authors:  Patricia López; Banesa de Paz; Javier Rodríguez-Carrio; Arancha Hevia; Borja Sánchez; Abelardo Margolles; Ana Suárez
Journal:  Sci Rep       Date:  2016-04-05       Impact factor: 4.379

Review 10.  Impact of sex disparities on the clinical manifestations in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

Authors:  Kamini Devi Boodhoo; Sijia Liu; Xiaoxia Zuo
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.